查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1928624

一步法RT-qPCR试剂盒市场按类型、目标分子、试剂盒规格、应用和终端用户，全球预测，2026-2032年

One Step RT-qPCR Kits Market by Type, Target Molecule, Kit Format, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，一步法 RT-qPCR 试剂盒市值将达到 10 亿美元，到 2026 年将成长到 11 亿美元，到 2032 年将达到 19.5 亿美元，复合年增长率为 9.92%。

关键市场统计数据
基准年 2025 10亿美元
预计年份：2026年 11亿美元
预测年份 2032 19.5亿美元
复合年增长率 (%) 9.92%

本书权威地介绍了一步法RT-qPCR试剂盒，说明了其技术目标、操作优势以及这些试剂盒在实验室中日益重要的作用。

一步法RT-qPCR试剂盒将逆转录和定量PCR结合在单一反应中，简化了科学研究、临床和工业实验室中RNA标靶的定量工作流程。这些试剂盒旨在透过将两个酶促反应步骤整合到一个优化的试剂系统中，最大限度地减少操作时间、降低污染风险并提高通量。酵素混合物、缓衝液化学和萤光检测相容性的技术改进，已将一步法试剂盒的效用从紧急感染疾病诊断扩展到常规基因表现研究和品管检测。

技术创新、监管压力和供应链演变正在共同重塑一步法RT-qPCR的格局，并推动其在各实验室的永续应用。

由于技术、监管和操作等多方面因素的共同作用，一步法RT-qPCR技术格局发生了翻天覆地的变化。酵素工程和多重探针化学的进步显着提高了检测的特异性和通量，使得复杂检测组合的分析步骤得以简化。同时，冷冻干预混液和无需仪器的製剂的出现降低了物流成本，实现了分散式检查和远端实验室操作。

关税环境变化对一步法RT-qPCR试剂盒相关人员的策略影响：对供应链结构、定价策略和区域製造地选择的影响

近期贸易政策和关税结构的变化给国际供应链上的製造商和买家带来了新的考量。影响试剂、塑胶和进口设备的关税调整正在改变到岸成本，并影响采购决策，促使供应商和买家重新评估筹资策略。为此，许多企业正在实现供应来源多元化、部分生产流程本地化，并调整库存管理方式，以保护自身营运免受进口关税波动的影响。

透过整合化学形式、应用需求、最终用户检验需求、目标分子考量以及试剂盒形式物流，制定产品策略。

了解这种市场细分对于使产品设计、行销和分销策略与最终用户需求和技术要求保持一致至关重要。在试剂盒类型中，市场可区分基于染料和基于探针的化学方法。基于染料的系统，例如 EvaGreen 和 SYBR Green，提供经济高效的检测，适用于广泛的表达谱分析。同时，基于探针的形式，例如 Molecular Beacon、Scorpions 和 TaqMan 探针，具有更高的特异性和多重检测能力，是诊断和靶向检测的首选。应用主导的需求涵盖癌症筛检、药物研发、环境检测、食品安全、基因表现分析和传染病检查等领域，每个领域都有不同的性能优先级，从灵敏度和定量准确性到法规遵从性和样本处理能力。

区域趋势正在影响美洲、欧洲、中东和非洲以及亚太市场的产品设计、商业化和支援策略。

区域趋势将深刻影响产品设计、分销和客户参与策略。在美洲，强大的临床和製药业对可靠的试剂、监管文件和值得信赖的供应链有着极高的要求，因此，能够证明产品性能检验且具备可扩展生产能力的供应商更受青睐。在欧洲、中东和非洲，不同的管理体制和检查室基础设施要求供应商提供灵活的产品系列和区域性支援模式，以应对不断变化的市场接受度和公共卫生优先事项。在亚太地区，对研究基础设施的快速投资、不断扩大的临床试验能力以及区域内生产能力的提升，为全球和本地供应商与学术界和产业界实验室合作，推进检验和本地化工作创造了机会。

决定一步法RT-qPCR试剂盒市场中企业长期成功的关键竞争要素与经营模式选择

在一步法RT-qPCR试剂盒领域，竞争优势的建构依赖技术差异化、监管应对力、供应链可靠性和客户支援能力的综合考量。主要企业通常会投资于酵素製剂、专有探针化学以及确保批次间一致性的完善品质系统的研究。与仪器製造商、契约製造製造商和分销网络建立策略联盟，有助于拓展市场并缓解产能瓶颈。

就产品创新、供应链韧性、法规遵循和客户参与等方面提出切实可行的建议，以加速产品推广和商业性成功。

产业领导者应采取多管齐下的策略，将技术创新、供应链韧性和以客户为中心的商业化结合在一起。应优先开发稳健的酵素系统和探针化学方法，在确保灵敏度、特异性和多重检测能力的同时，确保与常用qPCR仪器的兼容性。此外，还应考虑投资开发其他试剂盒形式，例如冷冻干预混液，以解决物流限制并扩大市场进入。

为确保可行性和准确性，我们采用了一种稳健的混合方法研究方法，该方法整合了对关键相关人员的访谈、对二手文献的三角验证以及实验室性能检验。

本分析的调查方法结合了初步定性研究结果、二手文献综述以及与实验室性能数据的交叉检验。主要资料来源包括对学术界、临床和工业实验室主任、采购负责人以及技术应用专家的结构化访谈，以了解决策驱动因素和检验标准。二级资讯来源包括同行评审文献、监管指导文件以及已发表的技术白皮书，这些资料阐述了酶技术、探针化学和试剂盒形式的相关背景。

本文概述了决定一步法RT-qPCR领域未来成功的策略要务、技术重点和营运槓桿。

总之，一步法RT-qPCR试剂盒在现代分子工作流程中发挥至关重要的作用，能够有效可靠地进行RNA定量，并适用于广泛的应用。酵素化学、探针设计和试剂盒形式的创新正在拓展其应用范围，使其从科研环境扩展到受监管的临床和工业领域。同时，供应链和法规环境的变化趋势也持续影响其应用路径。那些能够将产品开发与特定应用需求、区域营运实务和严格的检验要求结合的相关人员，将更有利于把握持续的市场需求。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依类型分類的一步法RT-qPCR试剂盒市场

  • 染料
    • 常绿
    • SYBR Green
  • 探针基座
    • 分子信标
    • 蝎
    • TaqMan探针

9. Target Molecule 的一步法 RT-qPCR 试剂盒市场

  • 细菌
  • DNA病毒
  • 微型RNA
  • RNA病毒

10. 依试剂盒类型分類的一步法RT-qPCR试剂盒市场

  • 液体
  • 冷冻干燥
  • 母带混音

第十一章：依应用分類的一步法RT-qPCR试剂盒市场

  • 癌症筛检
  • 药物发现
  • 环境检查
  • 食品检验
  • 基因表现分析
  • 感染疾病

第十二章：依最终用户分類的一步法RT-qPCR试剂盒市场

  • 学术机构
  • 临床诊断
  • 製药和生物技术公司
  • 研究所

13. 依地区分類的一步法RT-qPCR试剂盒市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：依组别分類的一步法RT-qPCR试剂盒市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各国一步法RT-qPCR试剂盒市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国一步法RT-qPCR试剂盒市场

第十七章：中国一步法RT-qPCR试剂盒市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Applied Biological Materials Inc.
  • Avantor, Inc.
  • Bio-Rad Laboratories, Inc.
  • Fortis Life Sciences, Inc.
  • Merck KGaA
  • New England Biolabs, Inc.
  • Promega Corporation
  • QIAGEN NV
  • Quantabio, Inc.
  • Roche Holding AG
  • Solis BioDyne, Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • TIANGEN Biotech（Beijing）Co., Ltd.
  • Zymo Research Corporation
Product Code: MRR-92740D85F074

The One Step RT-qPCR Kits Market was valued at USD 1.00 billion in 2025 and is projected to grow to USD 1.10 billion in 2026, with a CAGR of 9.92%, reaching USD 1.95 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.00 billion
Estimated Year [2026] USD 1.10 billion
Forecast Year [2032] USD 1.95 billion
CAGR (%) 9.92%

An authoritative introduction to one-step RT-qPCR kits covering technological purpose operational advantages and the expanding role these kits play across laboratories

One-step RT-qPCR kits combine reverse transcription and quantitative PCR in a single reaction, streamlining workflows that quantify RNA targets across research, clinical, and industrial laboratories. These kits are designed to minimize hands-on time, reduce contamination risk, and improve throughput by collapsing two enzymatic steps into a single, optimized reagent system. Technological refinements in enzyme blends, buffer chemistries, and fluorescence detection compatibility have expanded the usability of one-step kits beyond emergency infectious disease diagnostics into routine gene expression studies and quality control assays.

Early adopters appreciated the operational simplicity and reproducibility benefits, while later generations emphasized robustness across sample types and instrument platforms. As laboratories balance demands for speed and analytical sensitivity, one-step kits increasingly serve as a backbone reagent for high-throughput screening and targeted testing. Moreover, integration with lyophilized formats and master mixes addresses logistical constraints such as cold-chain dependency and batch-to-batch variability.

Transitioning from single-use demonstration deployments to standard lab protocols requires careful validation, but the overall trend is clear: one-step RT-qPCR kits are enabling laboratories to achieve faster turnaround, reproducible quantification, and simplified workflow management without sacrificing analytical rigor.

How converging technological innovation regulatory pressure and supply chain evolution are reshaping the one-step RT-qPCR landscape and driving sustainable adoption across labs

The one-step RT-qPCR landscape has undergone transformative shifts driven by converging technological, regulatory, and operational forces. Advances in enzyme engineering and multiplex probe chemistries have significantly enhanced assay specificity and throughput, enabling complex panels to be run with fewer manipulations. Meanwhile, the emergence of lyophilized master mixes and instrument-agnostic formulations has reduced logistical friction, enabling decentralized testing and remote laboratory operations.

Regulatory expectations and quality management practices have pushed suppliers to provide more robust documentation and lot-to-lot consistency, which in turn fosters broader adoption among clinical and pharmaceutical users who demand validated reagents. The pandemic response accelerated investment in rapid assay development and supply chain resilience; this momentum persisted as manufacturers focused on modular kit designs and global distribution strategies. At the same time, increasing demand for multiplex and high-sensitivity applications has steered innovation toward hybrid probe technologies and optimized buffer systems that maintain performance across diverse sample matrices.

Collectively, these shifts reflect a maturation of the market: vendors are balancing performance innovation with supply reliability and practical usability, while end users seek solutions that reduce complexity and integrate smoothly into existing laboratory ecosystems.

Strategic implications of evolving tariff landscapes on supply chain configuration pricing strategies and regional manufacturing choices for one-step RT-qPCR kit stakeholders

Recent changes in trade policy and tariff structures have introduced new considerations for manufacturers and purchasers operating across international supply chains. Tariff adjustments affecting reagents, plasticware, and imported instrumentation can alter landed costs and influence procurement decisions, prompting both suppliers and buyers to reassess sourcing strategies. In response, many organizations are diversifying supplier bases, localizing certain manufacturing steps, and reconfiguring inventory practices to insulate operations from volatility in import duties.

Procurement teams are increasingly incorporating tariff sensitivity into vendor selection criteria, evaluating not only price and performance but also the geographic footprint of suppliers and their ability to absorb or mitigate duty impacts. For manufacturers, shifting tariffs can affect margin structures and may incentivize establishing regional distribution centers or contract manufacturing partnerships to preserve competitiveness. At the same time, downstream users-such as clinical labs and research institutions-are adjusting budgetary planning to account for potential price variability and longer lead times associated with cross-border logistics.

Ultimately, the cumulative impact of tariffs is less about single-point cost increases and more about the strategic reorientation of supply chains, pricing models, and regional manufacturing footprints to maintain product availability and cost-effectiveness under evolving trade regimes.

Integrated segmentation analysis linking chemistry formats application requirements end-user validation needs target molecule considerations and kit format logistics to inform product strategy

Understanding segmentation is essential to aligning product design, marketing, and distribution strategies with end-user needs and technical requirements. Within kit type, the market differentiates between dye-based and probe-based chemistries; dye-based systems, including EvaGreen and SYBR Green, offer cost-effective detection suitable for broad expression profiling, whereas probe-based formats such as Molecular Beacon, Scorpions, and TaqMan probes provide higher specificity and multiplexing capability, making them preferable for diagnostics and targeted assays. Application-driven demand spans cancer screening, drug discovery, environmental testing, food safety, gene expression profiling, and infectious disease testing, each with distinct performance priorities ranging from sensitivity and quantitation accuracy to regulatory compliance and sample throughput.

End-user segmentation reveals diverse validation requirements and purchasing behaviors: academic institutes and research institutes prioritize flexibility and open-system compatibility, clinical diagnostics entities emphasize certified performance and regulatory traceability, while pharmaceutical and biotech companies demand batch consistency, scalable supply, and documentation suitable for regulated workflows. Target molecule considerations-bacteria, DNA viruses, microRNA, and RNA viruses-drive assay design choices around extraction compatibility, reverse transcription efficiency, and probe selection. Kit format options, including liquid, lyophilized, and master mix preparations, influence logistics, shelf life, and ease of deployment; lyophilized formats reduce cold-chain dependence and are attractive for field or decentralized testing, while master mixes support high-throughput laboratory automation.

By mapping these segment layers together, stakeholders can prioritize product features that align with specific application needs and end-user constraints, thereby improving adoption rates and commercial precision.

Regional dynamics shaping product design commercialization and support strategies across the Americas Europe Middle East Africa and Asia-Pacific markets

Regional dynamics profoundly shape product design, distribution, and customer engagement strategies. In the Americas, strong clinical and pharmaceutical sectors demand high-assurance reagents, regulatory documentation, and reliable supply chains; this market favors suppliers who can demonstrate validated performance and scalable manufacturing. The Europe, Middle East & Africa region features a heterogeneous set of regulatory regimes and laboratory infrastructures, which necessitates flexible product portfolios and localized support models to address variable adoption curves and public health priorities. In Asia-Pacific, rapid investment in research infrastructure, expanding clinical testing capacity, and an increasing number of regional manufacturing capabilities create opportunities for both global and local suppliers to partner with academic and industrial laboratories on validation and localization efforts.

Each region also differs in logistics constraints, procurement practices, and funding cycles; suppliers that tailor their commercial approach-whether through regional warehousing, strategic distributor partnerships, or localized technical services-tend to accelerate uptake. Moreover, regional public health initiatives and research funding priorities influence demand patterns for specific applications such as infectious disease surveillance or cancer screening programs. Adapting product formats, documentation, and go-to-market strategy to regional expectations will be pivotal for suppliers aiming to sustain growth and build resilient customer relationships across diverse geographies.

Key competitive imperatives and business model choices that determine long-term success for companies operating in the one-step RT-qPCR kit market

Competitive positioning in the one-step RT-qPCR kit arena rests on a blend of technical differentiation, regulatory readiness, supply chain reliability, and customer support capability. Leading companies typically invest in enzyme formulation research, proprietary probe chemistries, and robust quality systems to deliver consistent lot-to-lot performance. Strategic partnerships with instrument manufacturers, contract manufacturers, and distribution networks extend market reach while mitigating capacity constraints.

Companies that excel in this space often emphasize value-added services such as protocol optimization, on-site validation support, and documentation packages tailored for clinical and pharmaceutical end users. Others focus on cost leadership through streamlined manufacturing and alternative formats like lyophilized reagents to target resource-limited settings. Intellectual property around enzyme blends and probe designs can create barriers to entry, but modular licensing and collaborative development agreements remain viable paths for smaller innovators to scale.

Finally, reputation for supply continuity and transparent communication during supply disruptions is a competitive advantage; purchasers prioritize vendors that can demonstrate contingency planning, flexible production capacity, and clear timelines for order fulfillment. The interplay between innovation and operational excellence ultimately determines which companies sustain long-term relationships with demanding end users.

Actionable recommendations for product innovation supply chain resilience regulatory preparedness and customer engagement to accelerate adoption and commercial success

Industry leaders should adopt a multipronged approach that combines technical innovation with supply chain resilience and customer-centric commercialization. Prioritize development of robust enzyme systems and probe chemistries that balance sensitivity, specificity, and multiplex capability while ensuring compatibility across commonly used qPCR instruments. Invest in alternative kit formats, such as lyophilized master mixes, to address logistical constraints and broaden market accessibility.

Concurrently, strengthen regional manufacturing and distribution footprints to mitigate tariff exposure and reduce lead times. Establish transparent contingency plans with contract manufacturers and strategic distributors to ensure continuity during demand surges or trade disruptions. Enhance regulatory readiness by providing comprehensive documentation, validation data, and application notes tailored to clinical and pharmaceutical customers. Foster partnerships with clinical laboratories and research institutions to co-develop assays that address real-world sample matrices and workflow constraints.

Finally, adopt outcome-oriented commercial models that include technical support, training, and validation services, thereby lowering adoption barriers and demonstrating value beyond the reagent. These steps will help organizations translate technical capability into sustainable market advantages and resilient customer relationships.

Robust mixed-methods research approach integrating primary stakeholder interviews secondary literature triangulation and laboratory performance validation to ensure actionable accuracy

The research methodology underpinning this analysis combines primary qualitative insights, secondary literature synthesis, and cross-validation with laboratory performance data. Primary inputs included structured interviews with laboratory directors, procurement leads, and technical application specialists across academic, clinical, and industrial settings to capture decision drivers and validation criteria. Secondary sources encompassed peer-reviewed literature, regulatory guidance documents, and publicly available technical white papers that contextualize enzyme technologies, probe chemistries, and kit formats.

Analytical steps involved mapping segmentation layers to observed adoption patterns, assessing the operational implications of kit formats, and evaluating the effects of trade and logistics on procurement behavior. Performance characteristics cited in the report were cross-referenced with manufacturer technical sheets and independent validation studies to ensure factual accuracy and reproducibility of conclusions. Sensitivity checks were applied when interpreting stakeholder perspectives to reduce bias and to highlight diverging priorities among end users.

This mixed-methods approach ensures that recommendations are grounded in both technical reality and market behavior, providing a pragmatic foundation for strategic decision-making and product development planning.

Concluding synthesis highlighting the strategic imperatives technical priorities and operational levers that will determine future success in the one-step RT-qPCR landscape

In conclusion, one-step RT-qPCR kits occupy a pivotal role in modern molecular workflows by delivering streamlined, reliable RNA quantification suitable for a broad array of applications. Innovations in enzyme chemistry, probe design, and kit formats have expanded applicability from research settings into regulated clinical and industrial environments, while supply chain and regulatory dynamics continue to influence adoption pathways. Stakeholders who align product development with application-specific requirements, regional operational realities, and rigorous validation expectations will be best positioned to capture sustained demand.

The evolving landscape favors suppliers that combine technical excellence with operational resilience and customer-focused services. By addressing logistical constraints through format innovation and by enhancing regional support capabilities, manufacturers can reduce adoption barriers and foster long-term partnerships with demanding end users. Strategic attention to regulatory documentation and robust validation support will further differentiate vendors in increasingly quality-driven procurement environments.

Taken together, these elements form the basis of a pragmatic roadmap for organizations seeking to strengthen their presence in the one-step RT-qPCR space and to translate scientific capability into commercial impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. One Step RT-qPCR Kits Market, by Type

  • 8.1. Dye Based
    • 8.1.1. EvaGreen
    • 8.1.2. SYBR Green
  • 8.2. Probe Based
    • 8.2.1. Molecular Beacon
    • 8.2.2. Scorpions
    • 8.2.3. TaqMan Probe

9. One Step RT-qPCR Kits Market, by Target Molecule

  • 9.1. Bacteria
  • 9.2. DNA Viruses
  • 9.3. MicroRNA
  • 9.4. RNA Viruses

10. One Step RT-qPCR Kits Market, by Kit Format

  • 10.1. Liquid
  • 10.2. Lyophilized
  • 10.3. Master Mix

11. One Step RT-qPCR Kits Market, by Application

  • 11.1. Cancer Screening
  • 11.2. Drug Discovery
  • 11.3. Environmental Testing
  • 11.4. Food Testing
  • 11.5. Gene Expression Profiling
  • 11.6. Infectious Disease

12. One Step RT-qPCR Kits Market, by End User

  • 12.1. Academic Institutes
  • 12.2. Clinical Diagnostics
  • 12.3. Pharmaceutical & Biotech Companies
  • 12.4. Research Institutes

13. One Step RT-qPCR Kits Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. One Step RT-qPCR Kits Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. One Step RT-qPCR Kits Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States One Step RT-qPCR Kits Market

17. China One Step RT-qPCR Kits Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Applied Biological Materials Inc.
  • 18.6. Avantor, Inc.
  • 18.7. Bio-Rad Laboratories, Inc.
  • 18.8. Fortis Life Sciences, Inc.
  • 18.9. Merck KGaA
  • 18.10. New England Biolabs, Inc.
  • 18.11. Promega Corporation
  • 18.12. QIAGEN N.V.
  • 18.13. Quantabio, Inc.
  • 18.14. Roche Holding AG
  • 18.15. Solis BioDyne, Inc.
  • 18.16. Takara Bio Inc.
  • 18.17. Thermo Fisher Scientific Inc.
  • 18.18. TIANGEN Biotech (Beijing) Co., Ltd.
  • 18.19. Zymo Research Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ONE STEP RT-QPCR KITS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ONE STEP RT-QPCR KITS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ONE STEP RT-QPCR KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ONE STEP RT-QPCR KITS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY EVAGREEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY EVAGREEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY EVAGREEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY SYBR GREEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY SYBR GREEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY SYBR GREEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY MOLECULAR BEACON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY MOLECULAR BEACON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY MOLECULAR BEACON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY SCORPIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY SCORPIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY SCORPIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY TAQMAN PROBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY TAQMAN PROBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY TAQMAN PROBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY BACTERIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY BACTERIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY BACTERIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY DNA VIRUSES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY DNA VIRUSES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY DNA VIRUSES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY MICRORNA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY MICRORNA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY MICRORNA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY RNA VIRUSES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY RNA VIRUSES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY RNA VIRUSES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY LYOPHILIZED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY LYOPHILIZED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY LYOPHILIZED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY MASTER MIX, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY MASTER MIX, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY MASTER MIX, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY CANCER SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY CANCER SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY CANCER SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY ENVIRONMENTAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY ENVIRONMENTAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY FOOD TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY FOOD TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY FOOD TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY GENE EXPRESSION PROFILING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY GENE EXPRESSION PROFILING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY GENE EXPRESSION PROFILING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY INFECTIOUS DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS ONE STEP RT-QPCR KITS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA ONE STEP RT-QPCR KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA ONE STEP RT-QPCR KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA ONE STEP RT-QPCR KITS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE ONE STEP RT-QPCR KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST ONE STEP RT-QPCR KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA ONE STEP RT-QPCR KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC ONE STEP RT-QPCR KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN ONE STEP RT-QPCR KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. GCC ONE STEP RT-QPCR KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GCC ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. GCC ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, 2018-2032 (USD MILLION)
  • TABLE 158. GCC ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, 2018-2032 (USD MILLION)
  • TABLE 159. GCC ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
  • TABLE 160. GCC ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 161. GCC ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. GCC ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION ONE STEP RT-QPCR KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS ONE STEP RT-QPCR KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. G7 ONE STEP RT-QPCR KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. G7 ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. G7 ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, 2018-2032 (USD MILLION)
  • TABLE 182. G7 ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, 2018-2032 (USD MILLION)
  • TABLE 183. G7 ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
  • TABLE 184. G7 ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 185. G7 ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. G7 ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. NATO ONE STEP RT-QPCR KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. NATO ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. NATO ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, 2018-2032 (USD MILLION)
  • TABLE 190. NATO ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, 2018-2032 (USD MILLION)
  • TABLE 191. NATO ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
  • TABLE 192. NATO ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 193. NATO ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. NATO ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL ONE STEP RT-QPCR KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES ONE STEP RT-QPCR KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED STATES ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA ONE STEP RT-QPCR KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA ONE STEP RT-QPCR KITS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA ONE STEP RT-QPCR KITS MARKET SIZE, BY DYE BASED, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA ONE STEP RT-QPCR KITS MARKET SIZE, BY PROBE BASED, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA ONE STEP RT-QPCR KITS MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
  • TABLE 209. CHINA ONE STEP RT-QPCR KITS MARKET SIZE, BY KIT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 210. CHINA ONE STEP RT-QPCR KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA ONE STEP RT-QPCR KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)